Additive to Existing Therapies GLP-1s can be additive to existing anti-addiction treatments
There is growing interest in drug therapies that can support weight loss and thereby reduce the prevalence of obesity and obesity-related complications
In addition to the role of iron metabolism in ferroptosis, an increasing number of other metabolic pathways have been implicated in ferroptosis, including the cyst(e)ine/glutathione (GSH)/glutathione peroxidase 4 (GPX4) axis, the guanosine triphosphate cyclohydrolase 1 (GCH1)/tetrahydrobiopterin (BH 4 )/dihydrofolate reductase (DHFR) axis, and the ferroptosis suppressor protein 1 (FSP1)/ coenzyme Q (CoQ) axis [8]
I strongly recommend that everyone, especially women of childbearing age, get an MTHFR mutation test
Takeaways: - Cryoneurolysis with current argon-based methods may not reliably reach low enough temperatures in large proximal nerves
In addition to the effects of necrosis and apoptosis, other regulatory pathways, such as autophagy and necroptosis, have been proposed to play important roles in fat graft survival [26, 27]